These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3162752)

  • 1. Immunophenotype of clonogenic cells in myeloid leukaemia.
    Kabral A; Bradstock KF; Grimsley P; Favaloro EJ
    Leuk Res; 1988; 12(1):51-9. PubMed ID: 3162752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotype of blast cells in acute myeloid leukemia may be a useful predictive factor for outcome.
    Tucker J; Dorey E; Gregory WM; Simpson AP; Amess JA; Lister TA; Horton MA
    Hematol Oncol; 1990; 8(1):47-58. PubMed ID: 2404842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface phenotype of clonogenic cells in acute myeloid leukemia defined by monoclonal antibodies.
    Lange B; Ferrero D; Pessano S; Palumbo A; Faust J; Meo P; Rovera G
    Blood; 1984 Sep; 64(3):693-700. PubMed ID: 6590096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic analysis of clonogenic cells in acute lymphoblastic leukemia using an in vitro colony assay.
    Hudson AM; Makrynikola V; Kabral A; Bradstock KF
    Blood; 1989 Nov; 74(6):2112-20. PubMed ID: 2804349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia.
    Pombo de Oliveira MS; Matutes E; Rani S; Morilla R; Catovsky D
    Acta Haematol; 1988; 80(2):61-4. PubMed ID: 2901804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phenotype of L-CFU and its correlation with the immunological characteristics of the blast cell population in AML.
    del Cañizo MC; Almeida J; San Miguel JF; Orfao A; Gonzalez M; Lopez Borrasca A
    Ann Hematol; 1994 May; 68(5):233-6. PubMed ID: 8018763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic phenotype of the myeloid leukaemic cells defined by monoclonal antibodies.
    Robak T; Korycka A
    Arch Immunol Ther Exp (Warsz); 1987; 35(1):33-42. PubMed ID: 3477133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells.
    Robak T; Dowding C; Garewal G; Hibbin JA; Th'ng KH; Goldman JM
    Br J Haematol; 1986 Sep; 64(1):133-48. PubMed ID: 2428394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of clonogenic cells in acute myeloblastic leukemia.
    Sabbath KD; Ball ED; Larcom P; Davis RB; Griffin JD
    J Clin Invest; 1985 Feb; 75(2):746-53. PubMed ID: 3855866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
    Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable differentiation of human acute myeloid leukaemia during colony formation in vitro: a membrane marker analysis with monoclonal antibodies.
    Touw I; Löwenberg B
    Br J Haematol; 1985 Jan; 59(1):37-44. PubMed ID: 3882131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-.
    Blair A; Hogge DE; Sutherland HJ
    Blood; 1998 Dec; 92(11):4325-35. PubMed ID: 9834239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of monoclonal antibodies in the antigenic characteristics of normal myeloid progenitor cells and clonogenic blasts in acute myeloid leukaemia.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):71-84. PubMed ID: 3233065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10).
    Geller RB; Zahurak M; Hurwitz CA; Burke PJ; Karp JE; Piantadosi S; Civin CI
    Br J Haematol; 1990 Nov; 76(3):340-7. PubMed ID: 1702006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE; Cruse JM; Webb RN; Sanders CM; Beason K
    Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.